Loading clinical trials...

A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT04102501

A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia

The purpose of this study is to assess the Efficacy, Long Term Safety and Tolerability of RT001 in subjects with Friedreich's Ataxia

Lead sponsor: Biojiva LLC•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Biomarkers in Friedreich's Ataxia

NCT02497534 · Friedreich's Ataxia

RECRUITING

Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)

NCT02316314 · Friedreich's Ataxia

RECRUITINGNA

Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome.

NCT07095062 · Friedreich's Ataxia, Motor Disorders

Not Yet RecruitingNA

Cardiac Output and Fatigue in Friedreich's Ataxia

NCT07444333 · Friedreich's Ataxia

COMPLETEDPhase 3

Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia

NCT02415127 · Friedreich's Ataxia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 27, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment65

Start dateOct 2019

Last updatedMay 27, 2022

Condition

Friedreich's Ataxia

Locations shown

Collaborative Neuroscience Network, LLC

Long Beach, California

UCLA

Los Angeles, California

University of Florida

Gainesville, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 27, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions